Nanopore Technologies Market by Product (Instruments and Consumables), Application (DNA Sequencing and RNA Sequencing), and End User (Hospitals & Clinics, Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4621804
- 185 Pages
- July 2021
- Medical Devices
Nanopore sequencing is one of the techniques of third generation that is used in the sequencing of biopolymers, involving polynucleotides in the form of DNA or RNA and other components. Nanopore sequencing is a technique to analyze single molecule DNA or RNA that can be sequenced without the need for PCR amplification or chemical labeling of the sample. Furthermore, this sequencing has the potential to offer relatively lesser cost of genotyping, higher mobility for testing, and quick processing of samples with the ability to show results in real time. This is one of the latest generations in sequencing technologies, which helps in determining the order of nucleotides in DNA or in RNA. This technology can be used for measuring fluctuations in an electric current as the molecule passes through a nanopore, thus helping to identify the sequence of the given nucleic acid
Increase in R&D on nanopore technologies such that they can be used for novel viruses is expected to help the market gain traction during the forecast period. The increase in demand for DNA sequencing for various application for research would help the nanopore technologies market gain traction during the forecast period and increase in the use of epigenetics for the development of newer treatment methods propel the growth of the market. The introduction of Internet of Things benefits the nanopore technology, as sequencers can be easily connected to other technical systems, which will help healthcare professionals monitor the DNA sample on shared cloud computing labs and is anticipated to aid the market grow in the forecast period. This convergence of numerous technologies such as ultrafast nanopore sequencing, biosensors, the Internet of things (IoT), cloud computing, computational intelligence algorithms, and other related technologies would gradually expanding the applications of genomics to a wider range of needs. In addition, Nanopore-based sequencers, as the fourth-generation DNA sequencing technology, have the potential to quickly and reliably sequence the entire human genome for less than USD1000, and possibly for even less than USD100. The single-molecule techniques used by this technology allow to further study the interaction between DNA and protein, as well as between protein and protein.
However, issues faced to maintain the integration and structure of the nucleotide bases hinder the growth of the nanopore technologies market. Conversely, surge in use of nanopore technologies for fourth generation DNA sequencing is anticipated to offer lucrative opportunity for the market growth in the coming years. Nanopore-based sequencers, as the fourth-generation DNA sequencing technology, have the potential to quickly and reliably sequence the entire human genome for less than USD 1000, and possibly for even less than USD 100. This decrease in cost of nanopore technologies for the use in analysis of the type of sequence, will gain attention of majority of healthcare professions and hence will help the market gain traction during the forecast period.
The global nanopore technologies market is segmented into product, application, and region. On the basis of product, the market is categorized into instruments and consumables. The instruments segment is further segregated into portable and benchtop. The applications covered in the study include DNA sequencing and RNA sequencing. On the basis of end users, the market is segregated into hospitals & clinics, research institutes and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America is expected gain its dominance during the forecast period, owing to increase in demand for nanopore technologies, surge in incidences of viral diseases, and presence of major key players across the region. In addition, the surge in targeted patient population would contribute towards growth of nanopore technologies in the North American region. Higher healthcare expenditure and surge in favorable government policies for research in nanopore technologies are expected to propel the growth of the market in the coming years. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to surge in number of hospitals equipped with nanopore technology modalities, coupled with huge surge in utilization of nanopore technologies. In addition, surge in geriatric population who are susceptible to suffer from viral diseases would propel the market growth in the next few years.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
• Instruments
o Portable
o Benchtop
• Consumables
By Application
• DNA Sequencing
• RNA Sequencing
By End User
• Hospitals & Clinics
• Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Cyclomics
• Electronic Biosciences, Inc.
• Grandomics
• INanoBio Inc.
• Qitan Technology
• Quantapore, Inc.
• Nabsys, Inc.
• Nonacus, Inc.
• ONTERA, Inc.
• Oxford Nanopore Technologies
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in R&D on nanopore technologies
3.5.1.2.Surge in demand for DNA sequencing
3.5.1.3.Rise in use of epigenetics for the development of new treatment methods
3.5.1.4.Advent of internet of things to benefit growth of nanopore technologies
3.5.2.Restraints
3.5.2.1.Difficulty in maintaining integration of the nucleotide bases
3.5.3.Opportunity
3.5.3.1.Increase in use of nanopore technologies for fourth generation DNA sequencing
3.5.4.Impact analysis
3.6.COVID-19 Impact Analysis on nanopore technologies Market
CHAPTER 4:NANOPORE TECHNOLOGIES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Instruments
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Portable
4.2.5.1.Market size and forecast
4.2.6.Benchtop
4.2.6.1.Market size and forecast
4.3.Consumables
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:NANOPORE TECHNOLOGIES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.DNA Sequencing
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.RNA Sequencing
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:NANOPORE TECHNOLOGIES MARKET, BY END USERS
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & Clinics
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Research Institutes
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country
6.4.Others
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.4.3.Market analysis, by country
CHAPTER 7:NANOPORE TECHNOLOGY MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America market size and forecast, by product
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by end users
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.Nanopore technology market, for U.S., by product
7.2.5.1.2.Nanopore technology market, for U.S., by application
7.2.5.1.3.Nanopore technology market, for U.S., by end users
7.2.5.2.Canada
7.2.5.2.1.Nanopore technology market, for Canada, by product
7.2.5.2.2.Nanopore technology market, for Canada, by application
7.2.5.2.3.Nanopore technology market, for Canada, by end users
7.2.5.3.Mexico
7.2.5.3.1.Nanopore technology market, for Mexico, by product
7.2.5.3.2.Nanopore technology market, for Mexico, by application
7.2.5.3.3.Nanopore technology market, for Mexico, by end users
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe market size and forecast, by product
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by end users
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Nanopore technology market, for Germany, by product
7.3.5.1.2.Nanopore technology market, for Germany, by application
7.3.5.1.3.Nanopore technology market, for Germany, by end users
7.3.5.2.France
7.3.5.2.1.Nanopore technology market, for France, by product
7.3.5.2.2.Nanopore technology market, for France, by application
7.3.5.2.3.Nanopore technology market, for France, by end users
7.3.5.3.UK
7.3.5.3.1.Nanopore technology market, for UK, by product
7.3.5.3.2.Nanopore technology market, for UK, by application
7.3.5.3.3.Nanopore technology market, for UK, by end users
7.3.5.4.Italy
7.3.5.4.1.Nanopore technology market, for Italy, by product
7.3.5.4.2.Nanopore technology market, for Italy, by application
7.3.5.4.3.Nanopore technology market, for Italy, by end users
7.3.5.5.Spain
7.3.5.5.1.Nanopore technology market, for Spain, by product
7.3.5.5.2.Nanopore technology market, for Spain, by application
7.3.5.5.3.Nanopore technology market, for Spain, by end users
7.3.5.6.Rest of Europe
7.3.5.6.1.Nanopore technology market, for Rest of Europe, by product
7.3.5.6.2.Nanopore technology market, for Rest of Europe, by application
7.3.5.6.3.Nanopore technology market, for Rest of Europe, by end users
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific market size and forecast, by product
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by end users
7.4.5.Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Nanopore technology market, for Japan, by product
7.4.5.1.2.Nanopore technology market, for Japan, by application
7.4.5.1.3.Nanopore technology market, for Japan, by end users
7.4.5.2.China
7.4.5.2.1.Nanopore technology market, for China, by product
7.4.5.2.2.Nanopore technology market, for China, by application
7.4.5.2.3.Nanopore technology market, for China, by end users
7.4.5.3.Australia
7.4.5.3.1.Nanopore technology market, for Australia, by product
7.4.5.3.2.Nanopore technology market, for Australia, by application
7.4.5.3.3.Nanopore technology market, for Australia, by end users
7.4.5.4.India
7.4.5.4.1.Nanopore technology market, for India, by product
7.4.5.4.2.Nanopore technology market, for India, by application
7.4.5.4.3.Nanopore technology market, for India, by end users
7.4.5.5.South Korea
7.4.5.5.1.Nanopore technology market, for South Korea, by product
7.4.5.5.2.Nanopore technology market, for South Korea, by application
7.4.5.5.3.Nanopore technology market, for South Korea, by end users
7.4.5.6.Rest of Asia-Pacific
7.4.5.6.1.Nanopore technology market, for Rest of Asia-Pacific, by product
7.4.5.6.2.Nanopore technology market, for Rest of Asia-Pacific, by application
7.4.5.6.3.Nanopore technology market, for Rest of Asia-Pacific, by end users
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA market size and forecast, by product
7.5.3.LAMEA market size and forecast, by application
7.5.4.LAMEA market size and forecast, by end users
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Nanopore technology market, for Brazil, by product
7.5.5.1.2.Nanopore technology market, for Brazil, by application
7.5.5.1.3.Nanopore technology market, for Brazil, by end users
7.5.5.2.Saudi Arabia
7.5.5.2.1.Nanopore technology market, for Saudi Arabia, by product
7.5.5.2.2.Nanopore technology market, for Saudi Arabia, by application
7.5.5.2.3.Nanopore technology market, for Saudi Arabia, by end users
7.5.5.3.South Africa
7.5.5.3.1.Nanopore technology market, for South Africa, by product
7.5.5.3.2.Nanopore technology market, for South Africa, by application
7.5.5.3.3.Nanopore technology market, for South Africa, by end users
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Nanopore technology market, for Rest of LAMEA, by product
7.5.5.4.2.Nanopore technology market, for Rest of LAMEA, by application
7.5.5.4.3.Nanopore technology market, for Rest of LAMEA, by end users
CHAPTER 8:COMPANY PROFILES
8.1.Cyclomics
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments
8.2.Electronic Biosciences, Inc.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.3.Grandomics.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.INanoBio Inc.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.Qitan Technology.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments
8.6.Quantapore, Inc.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.Nabsys Inc.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.Nonacus, Inc
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.9.ONTERA, Inc.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.10.Oxford Nanopore Technologies
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
TABLE 01.NANOPORE TECHNOLOGIES MARKET, BY PRODUCT, 2020–2030 ($THOUSAND)
TABLE 02.NANOPORE TECHNOLOGIES MARKET, FOR INSTRUMENTS, BY REGION, 2020–2030 ($THOUSAND)
TABLE 03.NANOPORE TECHNOLOGIES MARKET, FOR INSTRUMENTS, BY TYPE, 2020–2030, ($THOUSAND)
TABLE 04.NANOPORE TECHNOLOGIES MARKET, FOR CONSUMABLES, BY REGION, 2020–2030 ($THOUSAND)
TABLE 05.NANOPORE TECHNOLOGIES MARKET, BY APPLICATION, 2020–2030 ($THOUSAND)
TABLE 06.NANOPORE TECHNOLOGIES MARKET, FOR DNA SEQUENCING, BY REGION, 2020–2030 ($THOUSAND)
TABLE 07.NANOPORE TECHNOLOGIES MARKET, FOR RNA SEQUENCING, BY REGION, 2020–2030 ($THOUSAND)
TABLE 08.NANOPORE TECHNOLOGIES MARKET, BY PRODUCT, 2020–2030 ($THOUSAND)
TABLE 09.NANOPORE TECHNOLOGIES MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2020–2030 ($THOUSAND)
TABLE 10.NANOPORE TECHNOLOGIES MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2020–2030 ($THOUSAND)
TABLE 11.NANOPORE TECHNOLOGIES MARKET, FOR OTHERS, BY REGION, 2020–2030 ($THOUSAND)
TABLE 12.NANOPORE TECHNOLOGY MARKET, BY REGION, 2020–2030 ($THOUSAND)
TABLE 13.NANOPORE TECHNOLOGY MARKET, FOR NORTH AMERICA, BY PRODUCT, 2020–2030, ($THOUSAND)
TABLE 14.NANOPORE TECHNOLOGY MARKET, FOR NORTH AMERICA, BY APPLICATION, 2020–2030, ($THOUSAND)
TABLE 15.NANOPORE TECHNOLOGY MARKET, FOR NORTH AMERICA, BY END USERS, 2020–2030, ($THOUSAND)
TABLE 16.NANOPORE TECHNOLOGY MARKET, FOR NORTH AMERICA, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 17.NANOPORE TECHNOLOGY MARKET, FOR U.S., BY PRODUCT, 2020–2030
TABLE 18.NANOPORE TECHNOLOGY MARKET, FOR U.S., BY APPLICATION, 2020–2030
TABLE 19.NANOPORE TECHNOLOGY MARKET, FOR U.S., BY END USERS, 2020–2030
TABLE 20.NANOPORE TECHNOLOGY MARKET, FOR CANADA, BY PRODUCT, 2020–2030
TABLE 21.NANOPORE TECHNOLOGY MARKET, FOR CANADA, BY APPLICATION, 2020–2030
TABLE 22.NANOPORE TECHNOLOGY MARKET, FOR CANADA, BY END USERS, 2020–2030
TABLE 23.NANOPORE TECHNOLOGY MARKET, FOR MEXICO, BY PRODUCT, 2020–2030
TABLE 24.NANOPORE TECHNOLOGY MARKET, FOR MEXICO, BY APPLICATION, 2020–2030
TABLE 25.NANOPORE TECHNOLOGY MARKET, FOR MEXICO, BY END USERS, 2020–2030
TABLE 26.NANOPORE TECHNOLOGY MARKET, FOR EUROPE, BY PRODUCT, 2020–2030, ($THOUSAND)
TABLE 27.NANOPORE TECHNOLOGY MARKET, FOR EUROPE, BY APPLICATION, 2020–2030, ($THOUSAND)
TABLE 28.NANOPORE TECHNOLOGY MARKET, FOR EUROPE, BY END USERS, 2020–2030, ($THOUSAND)
TABLE 29.NANOPORE TECHNOLOGY MARKET, FOR EUROPE NANOPORE TECHNOLOGY MARKET, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 30.NANOPORE TECHNOLOGY MARKET, FOR GERMANY, BY PRODUCT, 2020–2030
TABLE 31.NANOPORE TECHNOLOGY MARKET, FOR GERMANY, BY APPLICATION, 2020–2030
TABLE 32.NANOPORE TECHNOLOGY MARKET, FOR GERMANY, BY END USERS, 2020–2030
TABLE 33.NANOPORE TECHNOLOGY MARKET, FOR FRANCE, BY PRODUCT, 2020–2030
TABLE 34.NANOPORE TECHNOLOGY MARKET, FOR FRANCE, BY APPLICATION, 2020–2030
TABLE 35.NANOPORE TECHNOLOGY MARKET, FOR FRANCE, BY END USERS, 2020–2030
TABLE 36.NANOPORE TECHNOLOGY MARKET, FOR UK, BY PRODUCT, 2020–2030
TABLE 37.NANOPORE TECHNOLOGY MARKET, FOR UK, BY APPLICATION, 2020–2030
TABLE 38.NANOPORE TECHNOLOGY MARKET, FOR UK, BY END USERS, 2020–2030
TABLE 39.NANOPORE TECHNOLOGY MARKET, FOR ITALY, BY PRODUCT, 2020–2030
TABLE 40.NANOPORE TECHNOLOGY MARKET, FOR ITALY, BY APPLICATION, 2020–2030
TABLE 41.NANOPORE TECHNOLOGY MARKET, FOR ITALY, BY END USERS, 2020–2030
TABLE 42.NANOPORE TECHNOLOGY MARKET, FOR SPAIN, BY PRODUCT, 2020–2030
TABLE 43.NANOPORE TECHNOLOGY MARKET, FOR SPAIN, BY APPLICATION, 2020–2030
TABLE 44.NANOPORE TECHNOLOGY MARKET, FOR SPAIN, BY END USERS, 2020–2030
TABLE 45.NANOPORE TECHNOLOGY MARKET, FOR REST OF EUROPE, BY PRODUCT, 2020–2030
TABLE 46.NANOPORE TECHNOLOGY MARKET, FOR REST OF EUROPE, BY APPLICATION, 2020–2030
TABLE 47.NANOPORE TECHNOLOGY MARKET, FOR REST OF EUROPE, BY END USERS, 2020–2030
TABLE 48.NANOPORE TECHNOLOGY MARKET, FOR ASIA-PACIFIC, BY PRODUCT, 2020–2030, ($THOUSAND)
TABLE 49.NANOPORE TECHNOLOGY MARKET, FOR ASIA-PACIFIC, BY APPLICATION, 2020–2030, ($THOUSAND)
TABLE 50.NANOPORE TECHNOLOGY MARKET, FOR ASIA-PACIFIC, BY END USERS, 2020–2030, ($THOUSAND)
TABLE 51.NANOPORE TECHNOLOGY MARKET, FOR ASIA-PACIFIC , BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 52.NANOPORE TECHNOLOGY MARKET, FOR JAPAN, BY PRODUCT, 2020–2030
TABLE 53.NANOPORE TECHNOLOGY MARKET, FOR JAPAN, BY APPLICATION, 2020–2030
TABLE 54.NANOPORE TECHNOLOGY MARKET, FOR JAPAN, BY END USERS, 2020–2030
TABLE 55.NANOPORE TECHNOLOGY MARKET, FOR CHINA, BY PRODUCT, 2020–2030
TABLE 56.NANOPORE TECHNOLOGY MARKET, FOR CHINA, BY APPLICATION, 2020–2030
TABLE 57.NANOPORE TECHNOLOGY MARKET, FOR CHINA, BY END USERS, 2020–2030
TABLE 58.NANOPORE TECHNOLOGY MARKET, FOR AUSTRALIA, BY PRODUCT, 2020–2030
TABLE 59.NANOPORE TECHNOLOGY MARKET, FOR AUSTRALIA, BY APPLICATION, 2020–2030
TABLE 60.NANOPORE TECHNOLOGY MARKET, FOR AUSTRALIA, BY END USERS, 2020–2030
TABLE 61.NANOPORE TECHNOLOGY MARKET, FOR INDIA, BY PRODUCT, 2020–2030
TABLE 62.NANOPORE TECHNOLOGY MARKET, FOR INDIA, BY APPLICATION, 2020–2030
TABLE 63.NANOPORE TECHNOLOGY MARKET, FOR INDIA, BY END USERS, 2020–2030
TABLE 64.NANOPORE TECHNOLOGY MARKET, FOR SOUTH KOREA, BY PRODUCT, 2020–2030
TABLE 65.NANOPORE TECHNOLOGY MARKET, FOR SOUTH KOREA, BY APPLICATION, 2020–2030
TABLE 66.NANOPORE TECHNOLOGY MARKET, FOR SOUTH KOREA, BY END USERS, 2020–2030
TABLE 67.NANOPORE TECHNOLOGY MARKET, FOR REST OF ASIA-PACIFIC, BY PRODUCT, 2020–2030
TABLE 68.NANOPORE TECHNOLOGY MARKET, FOR REST OF ASIA-PACIFIC, BY APPLICATION, 2020–2030
TABLE 69.NANOPORE TECHNOLOGY MARKET, FOR REST OF ASIA-PACIFIC, BY END USERS, 2020–2030
TABLE 70.NANOPORE TECHNOLOGY MARKET, FOR LAMEA, BY PRODUCT, 2020–2030, ($THOUSAND)
TABLE 71.NANOPORE TECHNOLOGY MARKET, FOR LAMEA, BY APPLICATION, 2020–2030, ($THOUSAND)
TABLE 72.NANOPORE TECHNOLOGY MARKET, FOR LAMEA, BY END USERS, 2020–2030, ($THOUSAND)
TABLE 73.NANOPORE TECHNOLOGY MARKET, FOR LAMEA, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 74.NANOPORE TECHNOLOGY MARKET, FOR BRAZIL, BY PRODUCT, 2020–2030
TABLE 75.NANOPORE TECHNOLOGY MARKET, FOR BRAZIL, BY APPLICATION, 2020–2030
TABLE 76.NANOPORE TECHNOLOGY MARKET, FOR BRAZIL, BY END USERS, 2020–2030
TABLE 77.NANOPORE TECHNOLOGY MARKET, FOR SAUDI ARABIA, BY PRODUCT, 2020–2030
TABLE 78.NANOPORE TECHNOLOGY MARKET, FOR SAUDI ARABIA, BY APPLICATION, 2020–2030
TABLE 79.NANOPORE TECHNOLOGY MARKET, FOR SAUDI ARABIA, BY END USERS, 2020–2030
TABLE 80.NANOPORE TECHNOLOGY MARKET, FOR SOUTH AFRICA, BY PRODUCT, 2020–2030
TABLE 81.NANOPORE TECHNOLOGY MARKET, FOR SOUTH AFRICA, BY APPLICATION, 2020–2030
TABLE 82.NANOPORE TECHNOLOGY MARKET, FOR SOUTH AFRICA, BY END USERS, 2020–2030
TABLE 83.NANOPORE TECHNOLOGY MARKET, FOR REST OF LAMEA, BY PRODUCT, 2020–2030
TABLE 84.NANOPORE TECHNOLOGY MARKET, FOR REST OF LAMEA, BY APPLICATION, 2020–2030
TABLE 85.NANOPORE TECHNOLOGY MARKET, FOR REST OF LAMEA, BY END USERS, 2020–2030
TABLE 86.CYCLOMICS: COMPANY SNAPSHOT
TABLE 87.CYCLOMICS: OPERATING SEGMENTS
TABLE 88.CYCLOMICS: PRODUCT PORTFOLIO
TABLE 89.ELECTRON BIOSCIENCES: COMPANY SNAPSHOT
TABLE 90.ELECTRONIC BIOSCIENCES: OPERATING SEGMENTS
TABLE 91.ELECTRONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 92.OMICS: COMPANY SNAPSHOT
TABLE 93.OMICS: OPERATING SEGMENTS
TABLE 94.OMICS: PRODUCT PORTFOLIO
TABLE 95.INANOBIO: COMPANY SNAPSHOT
TABLE 96.INANOBIO: OPERATING SEGMENTS
TABLE 97.INANOBIO: PRODUCT PORTFOLIO
TABLE 98.QITAN: COMPANY SNAPSHOT
TABLE 99.QITAN: OPERATING SEGMENTS
TABLE 100.QITAN: PRODUCT PORTFOLIO
TABLE 101.QUANTAPORE: COMPANY SNAPSHOT
TABLE 102.QUANTAPORE: OPERATING SEGMENTS
TABLE 103.QUANTAPORE: PRODUCT PORTFOLIO
TABLE 104.NABSYS: COMPANY SNAPSHOT
TABLE 105.NABSYS: OPERATING SEGMENTS
TABLE 106.NABSYS: PRODUCT PORTFOLIO
TABLE 107.NONACUS: COMPANY SNAPSHOT
TABLE 108.NONACUS: OPERATING SEGMENTS
TABLE 109.NONACUS: PRODUCT PORTFOLIO
TABLE 110.ONTERA COMPANY SNAPSHOT
TABLE 111.ONTERA: OPERATING SEGMENTS
TABLE 112.ONTERA: PRODUCT PORTFOLIO
TABLE 113.OXFORD COMPANY SNAPSHOT
TABLE 114.OXFORD: OPERATING SEGMENTS
TABLE 115.OXFORD: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
